APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Injection General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intravenous Injection General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchIntravenous Injection General Anesthesia Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Injection General Anesthesia Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Intravenous Injection General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Injection General Anesthesia Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Injection General Anesthesia Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Intravenous Injection General Anesthesia Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Injection General Anesthesia Drugs include Aspen Pharma, Hikma Pharmaceuticals, Maruishi, Maruishi, Piramal, AstraZeneca, AbbVie, Baxter Healthcare and B.Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous Injection General Anesthesia Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Injection General Anesthesia Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Injection General Anesthesia Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Injection General Anesthesia Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Injection General Anesthesia Drugs Segment by Company

Aspen Pharma

Hikma Pharmaceuticals

Maruishi

Maruishi

Piramal

AstraZeneca

AbbVie

Baxter Healthcare

B.Braun

Fresenius-Kabi

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Hengrui

Nhwa

Lunan Pharmaceutical Group Corporation

Xi'an Libang

Yichang Humanwell

Intravenous Injection General Anesthesia Drugs Segment by Type

Propofol

Sevoflurane

Remifentanil

Etomidate

Isoflurane

Other

Intravenous Injection General Anesthesia Drugs Segment by Application

Hopitals

Clinics

Others

Intravenous Injection General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Injection General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Injection General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Injection General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Injection General Anesthesia Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intravenous Injection General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intravenous Injection General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intravenous Injection General Anesthesia Drugs Industry Trends Table 2. Intravenous Injection General Anesthesia Drugs Industry Drivers Table 3. Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges Table 4. Intravenous Injection General Anesthesia Drugs Industry Restraints Table 5. Global Intravenous Injection General Anesthesia Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intravenous Injection General Anesthesia Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Manufacturers Table 9. Global Intravenous Injection General Anesthesia Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Intravenous Injection General Anesthesia Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intravenous Injection General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intravenous Injection General Anesthesia Drugs Manufacturers, Product Type & Application Table 13. Global Intravenous Injection General Anesthesia Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Injection General Anesthesia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Propofol Table 17. Major Manufacturers of Sevoflurane Table 18. Major Manufacturers of Remifentanil Table 19. Major Manufacturers of Etomidate Table 20. Major Manufacturers of Isoflurane Table 21. Major Manufacturers of Other Table 22. Global Intravenous Injection General Anesthesia Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 24. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 25. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2026) Table 26. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2027-2032) Table 27. Global Intravenous Injection General Anesthesia Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2026) & (k units) Table 29. Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2027-2032) & (k units) Table 30. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hopitals Table 33. Major Manufacturers of Clinics Table 34. Major Manufacturers of Others Table 35. Global Intravenous Injection General Anesthesia Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 37. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 38. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2026) Table 39. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2027-2032) Table 40. Global Intravenous Injection General Anesthesia Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2026) & (k units) Table 42. Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2027-2032) & (k units) Table 43. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2026) Table 44. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2027-2032) Table 45. Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2026) & (k units) Table 47. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 48. Global Intravenous Injection General Anesthesia Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Intravenous Injection General Anesthesia Drugs Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 52. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 53. Europe Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 55. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 62. Global Intravenous Injection General Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2021-2026) Table 66. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2027-2032) Table 67. Aspen Pharma Company Information Table 68. Aspen Pharma Business Overview Table 69. Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio Table 71. Aspen Pharma Recent Development Table 72. Hikma Pharmaceuticals Company Information Table 73. Hikma Pharmaceuticals Business Overview Table 74. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio Table 76. Hikma Pharmaceuticals Recent Development Table 77. Maruishi Company Information Table 78. Maruishi Business Overview Table 79. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 81. Maruishi Recent Development Table 82. Maruishi Company Information Table 83. Maruishi Business Overview Table 84. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 86. Maruishi Recent Development Table 87. Piramal Company Information Table 88. Piramal Business Overview Table 89. Piramal Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio Table 91. Piramal Recent Development Table 92. AstraZeneca Company Information Table 93. AstraZeneca Business Overview Table 94. AstraZeneca Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio Table 96. AstraZeneca Recent Development Table 97. AbbVie Company Information Table 98. AbbVie Business Overview Table 99. AbbVie Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio Table 101. AbbVie Recent Development Table 102. Baxter Healthcare Company Information Table 103. Baxter Healthcare Business Overview Table 104. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio Table 106. Baxter Healthcare Recent Development Table 107. B.Braun Company Information Table 108. B.Braun Business Overview Table 109. B.Braun Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio Table 111. B.Braun Recent Development Table 112. Fresenius-Kabi Company Information Table 113. Fresenius-Kabi Business Overview Table 114. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 116. Fresenius-Kabi Recent Development Table 117. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 118. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 119. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio Table 121. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Development Table 122. Hengrui Company Information Table 123. Hengrui Business Overview Table 124. Hengrui Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio Table 126. Hengrui Recent Development Table 127. Nhwa Company Information Table 128. Nhwa Business Overview Table 129. Nhwa Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio Table 131. Nhwa Recent Development Table 132. Lunan Pharmaceutical Group Corporation Company Information Table 133. Lunan Pharmaceutical Group Corporation Business Overview Table 134. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio Table 136. Lunan Pharmaceutical Group Corporation Recent Development Table 137. Xi'an Libang Company Information Table 138. Xi'an Libang Business Overview Table 139. Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio Table 141. Xi'an Libang Recent Development Table 142. Yichang Humanwell Company Information Table 143. Yichang Humanwell Business Overview Table 144. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio Table 146. Yichang Humanwell Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Intravenous Injection General Anesthesia Drugs Distributors List Table 150. Intravenous Injection General Anesthesia Drugs Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Intravenous Injection General Anesthesia Drugs Product Image Figure 2. Global Intravenous Injection General Anesthesia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Injection General Anesthesia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Injection General Anesthesia Drugs Sales (2021-2032) & (k units) Figure 5. Global Intravenous Injection General Anesthesia Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Intravenous Injection General Anesthesia Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Propofol Image Figure 9. Sevoflurane Image Figure 10. Remifentanil Image Figure 11. Etomidate Image Figure 12. Isoflurane Image Figure 13. Other Image Figure 14. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Intravenous Injection General Anesthesia Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2032) Figure 17. Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2032) Figure 20. Hopitals Image Figure 21. Clinics Image Figure 22. Others Image Figure 23. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Intravenous Injection General Anesthesia Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2032) Figure 26. Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2032) Figure 29. North America Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 31. U.S. Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 36. Germany Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 43. China Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 51. Brazil Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Intravenous Injection General Anesthesia Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 62. North America Intravenous Injection General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Europe Intravenous Injection General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Intravenous Injection General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Intravenous Injection General Anesthesia Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Intravenous Injection General Anesthesia Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol
  • Sevoflurane
  • Remifentanil
  • Etomidate
  • Isoflurane
  • Other
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Aspen Pharma
  • Hikma Pharmaceuticals
  • Maruishi
  • Maruishi
  • Piramal
  • AstraZeneca
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Fresenius-Kabi
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Hengrui
  • Nhwa
  • Lunan Pharmaceutical Group Corporation
  • Xi'an Libang
  • Yichang Humanwell

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intravenous Injection General Anesthesia Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intravenous Injection General Anesthesia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intravenous Injection General Anesthesia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intravenous Injection General Anesthesia Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intravenous Injection General Anesthesia Drugs Market Dynamics
  1. 2.1 Intravenous Injection General Anesthesia Drugs Industry Trends
  2. 2.2 Intravenous Injection General Anesthesia Drugs Industry Drivers
  3. 2.3 Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Intravenous Injection General Anesthesia Drugs Industry Restraints
3 Intravenous Injection General Anesthesia Drugs Market by Manufacturers
  1. 3.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intravenous Injection General Anesthesia Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intravenous Injection General Anesthesia Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intravenous Injection General Anesthesia Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Injection General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intravenous Injection General Anesthesia Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Intravenous Injection General Anesthesia Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Injection General Anesthesia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Injection General Anesthesia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Injection General Anesthesia Drugs Tier 1, Tier 2, and Tier 3
4 Intravenous Injection General Anesthesia Drugs Market by Type
  1. 4.1 Intravenous Injection General Anesthesia Drugs Type Introduction
  2. 4.1.1 Propofol
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Remifentanil
  5. 4.1.4 Etomidate
  6. 4.1.5 Isoflurane
  7. 4.1.6 Other
  8. 4.2 Global Intravenous Injection General Anesthesia Drugs Sales by Type
  9. 4.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032)
  11. 4.2.3 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2032)
  12. 4.3 Global Intravenous Injection General Anesthesia Drugs Revenue by Type
  13. 4.3.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2032)
  15. 4.3.3 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2032)
5 Intravenous Injection General Anesthesia Drugs Market by Application
  1. 5.1 Intravenous Injection General Anesthesia Drugs Application Introduction
  2. 5.1.1 Hopitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Injection General Anesthesia Drugs Sales by Application
  6. 5.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Intravenous Injection General Anesthesia Drugs Revenue by Application
  10. 5.3.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2032)
6 Global Intravenous Injection General Anesthesia Drugs Sales by Region
  1. 6.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Intravenous Injection General Anesthesia Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intravenous Injection General Anesthesia Drugs Revenue by Region
  1. 7.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Region
  2. 7.1.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intravenous Injection General Anesthesia Drugs Revenue (2021-2032)
  8. 7.2.2 North America Intravenous Injection General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intravenous Injection General Anesthesia Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Intravenous Injection General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intravenous Injection General Anesthesia Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intravenous Injection General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aspen Pharma
  2. 8.1.1 Aspen Pharma Company Information
  3. 8.1.2 Aspen Pharma Business Overview
  4. 8.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio
  6. 8.1.5 Aspen Pharma Recent Developments
  7. 8.2 Hikma Pharmaceuticals
  8. 8.2.1 Hikma Pharmaceuticals Company Information
  9. 8.2.2 Hikma Pharmaceuticals Business Overview
  10. 8.2.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio
  12. 8.2.5 Hikma Pharmaceuticals Recent Developments
  13. 8.3 Maruishi
  14. 8.3.1 Maruishi Company Information
  15. 8.3.2 Maruishi Business Overview
  16. 8.3.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  18. 8.3.5 Maruishi Recent Developments
  19. 8.4 Maruishi
  20. 8.4.1 Maruishi Company Information
  21. 8.4.2 Maruishi Business Overview
  22. 8.4.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  24. 8.4.5 Maruishi Recent Developments
  25. 8.5 Piramal
  26. 8.5.1 Piramal Company Information
  27. 8.5.2 Piramal Business Overview
  28. 8.5.3 Piramal Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio
  30. 8.5.5 Piramal Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 AbbVie
  38. 8.7.1 AbbVie Company Information
  39. 8.7.2 AbbVie Business Overview
  40. 8.7.3 AbbVie Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio
  42. 8.7.5 AbbVie Recent Developments
  43. 8.8 Baxter Healthcare
  44. 8.8.1 Baxter Healthcare Company Information
  45. 8.8.2 Baxter Healthcare Business Overview
  46. 8.8.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio
  48. 8.8.5 Baxter Healthcare Recent Developments
  49. 8.9 B.Braun
  50. 8.9.1 B.Braun Company Information
  51. 8.9.2 B.Braun Business Overview
  52. 8.9.3 B.Braun Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio
  54. 8.9.5 B.Braun Recent Developments
  55. 8.10 Fresenius-Kabi
  56. 8.10.1 Fresenius-Kabi Company Information
  57. 8.10.2 Fresenius-Kabi Business Overview
  58. 8.10.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio
  60. 8.10.5 Fresenius-Kabi Recent Developments
  61. 8.11 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  62. 8.11.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  63. 8.11.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  64. 8.11.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio
  66. 8.11.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  67. 8.12 Hengrui
  68. 8.12.1 Hengrui Company Information
  69. 8.12.2 Hengrui Business Overview
  70. 8.12.3 Hengrui Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio
  72. 8.12.5 Hengrui Recent Developments
  73. 8.13 Nhwa
  74. 8.13.1 Nhwa Company Information
  75. 8.13.2 Nhwa Business Overview
  76. 8.13.3 Nhwa Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio
  78. 8.13.5 Nhwa Recent Developments
  79. 8.14 Lunan Pharmaceutical Group Corporation
  80. 8.14.1 Lunan Pharmaceutical Group Corporation Company Information
  81. 8.14.2 Lunan Pharmaceutical Group Corporation Business Overview
  82. 8.14.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio
  84. 8.14.5 Lunan Pharmaceutical Group Corporation Recent Developments
  85. 8.15 Xi'an Libang
  86. 8.15.1 Xi'an Libang Company Information
  87. 8.15.2 Xi'an Libang Business Overview
  88. 8.15.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio
  90. 8.15.5 Xi'an Libang Recent Developments
  91. 8.16 Yichang Humanwell
  92. 8.16.1 Yichang Humanwell Company Information
  93. 8.16.2 Yichang Humanwell Business Overview
  94. 8.16.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio
  96. 8.16.5 Yichang Humanwell Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Injection General Anesthesia Drugs Value Chain Analysis
  2. 9.1.1 Intravenous Injection General Anesthesia Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Injection General Anesthesia Drugs Production Mode & Process
  6. 9.2 Intravenous Injection General Anesthesia Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Injection General Anesthesia Drugs Distributors
  9. 9.2.3 Intravenous Injection General Anesthesia Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst